Never Run Out Of Buyers To Sell To.

Moving from cell to blood based HPV cancer screening, Abviris has developed a new patented generation of Immune Oncology Diagnostics for the early detection of HPV induced cancer, allowing a blood based entire body screen within minutes by using just one drop of blood. Abviris addresses the globally increasing problem of cancer caused by the human papillomavirus (HPV). We are dedicated to improving the clinical outcomes of patients and enable clinicians worldwide to fight HPV-induced tumours, including head and neck cancer, penile and anal tumours, vaginal and vulvar cancer and of course…
Annual Revenue$10M to $25M
Estimated OwnershipBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.